Language selection

Search

Patent 1059118 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1059118
(21) Application Number: 1059118
(54) English Title: PREPARATION OF .beta.-LACTAM ANTIBIOTICS
(54) French Title: PREPARATION D'UN ANTIBIOTIQUE, LE .beta.-LACTAM
Status: Term Expired - Post Grant Beyond Limit
Bibliographic Data
(51) International Patent Classification (IPC):
  • C07D 499/16 (2006.01)
  • C07D 499/00 (2006.01)
  • C07D 501/04 (2006.01)
(72) Inventors :
  • BERRY, ANTONY R.
  • CAMBURN, IAN D.
(73) Owners :
  • BEECHAM GROUP LIMITED
(71) Applicants :
  • BEECHAM GROUP LIMITED (United Kingdom)
(74) Agent:
(74) Associate agent:
(45) Issued: 1979-07-24
(22) Filed Date:
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data: None

Abstracts

English Abstract


ABSTRACT OF THE DISCLOSURE
The present invention provides a process for the preparation
of a sodium or potassium salt of a .beta.-lactam antibiotic which contains a
.alpha.-amino group in the acylamino side chain which process comprises (a) the
formation of a slurry of the zwitterionic form of the antibiotic in an
organic solvent system which contains at least one lower alkanol;
(b) bringing about the dissolution of the antibiotic by the addition of a
sodium or potassium hydrozide or lower alkoxide; (c) precipitating the
resulting salt from solution by the addition of an organic solvent and
(d) isolating the precipitate. The process of this invention is
particularly suitable for the preparation of the sodium or potassium
salts of amoxycillin. Amoxycillin salts prepared by the process of this
invention can be of higher purity than those produced by conventional
procedures.


Claims

Note: Claims are shown in the official language in which they were submitted.


THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE PROPERTY OR PRIVILEGE
IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for the preparation of a sodium or potassium salt of a
.beta.-lactam antibiotic which contains a .alpha.-amino group in the acylamino side
chain which process comprises
(a) the formation of a slurry of the zwitterionic form of the antibiotic
in an organic solvent system which contains from 10-70% v/v of at least one
lower alkanol;
(b) bringing about the dissolution of the antibiotic by the addition
of a sodium or potassium hydroxide or lower alkoxide;
(c) precipitating the resulting salt from solution by the addition of
an organic solvent and
(d) isolating the precipitate.
2. A process according to claim 1 wherein the antibiotic is amoxycillin.
3. A process according to claim 2 wherein the lower alkanol in stage
(a) is methano, ethanol or isopropanol.
4. A process according to claim 2 wherein the lower alkanol in stage
(a) is methanol and the dissolution in stage (b) is brought about by the
addition of sodium methoxide.
5. A process according to claim 4 wherein the organic solvent used in
stage (c) is methylene dichloride.
6. A process for the preparation of the sodium or potassium salt of
amoxycillin which comprises
(a) the formation of a slurry of amoxycillin in a mixture of dichloro-
methane and from 10-70% v/v of methanol;
(b) bringing about the dissolution of the amoxycillin by the addition of
sodium methoxide or potassium methoxide at a temperature below 0°C;
(c) precipitating the resulting salt by the addition of an organic solvent;
and

(d) isolating the precipitated sodium or potassium salt of amoxycillin.
7. A process as claimed in claim 6 in which stage (b) is carried out at
a temperature below -10 C.
8. A process as claimed in claim 7 wherein the temperature is -20°C to
-25°C.
9. A process as in any of claims 6-8 wherein the organic solvent added
in stage (c) is dichloromethane.

Description

Note: Descriptions are shown in the official language in which they were submitted.


1059118
This invention relates to a method of preparing salts of
~-lactam antibiotics which contain a~ -amino group in the acylamino
side chain.
Alkali metal salts of amphoteric/ -lactam antibiotics such
as ampicillin, amoxycillin, cephaloglycine and the like have often
been prepared by the reaction of an alkali metal salt and an amine
salt of the antibiotic in an organic solvent. This method frequently
works well especially if water is excluded from the reaction system
(see, for example, U.K. Patent No. 1,286,199), but, in terms of
purity of the product, considerable scope is often left for improve-
ment in such processes. Up until the present invention, the devel-
opment of improved processes has been handicapped by the necessity
of using amines to help dissolve the antibiotic prior to reaction.
The present invention allows the desired alkali metal salts to be
prepared without first preparing an amine salt which can be bene-
ficial in terms of yields and purity of the final product.
Accordingly the present invention provides a process for the preparation
of a sodium or potassium salt of a ~-lactam antibiotic which contains
a ~-amino group in the acylamino side chain which process comprises
(a) the formation of a slurry of the zwitterionic form of the anti-
biotic in an organic solvent system which contains at least one lower
alkanol;(b) bringing about the dissolution of the antibiotic by the
addition of a sodium or potassium hydroxide or lower alkoxide; (c)
precipitating the resulting salt from solution by the addition of an
organic solvent and (d) isolating the precipitate.
This reaction sequence may be applied to semi-synthetic
penicillins or cephalosporins containing a group of the formula:
- 2 -- ~
'~ , , ' ' , :
' . . '~. ' :,', ,: "
, ~ , ' ' ,,
.' . , :.

1059118
Rl - CH - CO - NH -
I
NH2
at the 6- position of the penicillin ring or 7- position of the
cephalosporin ring; wherein Rl is a phenyl, cyclohexadienyl, thienyl
or p-hydroxyphenyl group. Thus, suitable antibiotics for use in the
process of this invention include ampicillin, amoxycillin, cephalo-
glycine, cephradin, cephalexin and the like. This reaction sequence
may prove particularly suitable for the preparation of~ -lactam anti-
biotics wherein Rl is a hydroxyphenyl group.
The process of this invention is particularly suitable
for the preparation of the sodium or potassium salts of amoxycillin.
Amoxycillin salts prepared by the process of this invention can be
of higher purity than those produced by conventional procedures.
When used herein, the term 'lower' means that the group contains
less than nine carbon atoms and more suitably less than six carbon
atoms.
The solvent system used in step (a) of the reaction se-
quence previously described should contain 10 - 70% v/v of lower
alkanol, more suitably 25 - 60% v/v of alkanol and should preferably,
contain 30 - 50~ v/v of alkanol. Suitable alkanols include methanol,
ethanol, n-propanol, iso-propanol and the butanols. Particularly
suitable alkanols include methanol, ethanol and n-propanol. Mixtures
of alkanols may be used but in general such mixtures are not pre-
ferred. In addition to its alkanolic component, this solvent system
will contain one or more solvents selected from conventional inert
organic solvents such as the hydrocarbon, chlorinated hydrocarbon,
ketonic or like solvents. The solvents may be mixed as described
provided that the final system contains at least 10% alkanol and has
.. . . . .

-- - lOS9118
a dielectric of at least 8 and more suitably at least 12. A pre-
ferred solvent system is a mixture of dichloromethane and methanol,
especially when the methanol is present in the proportions indicated
above.
For step (a), the concentration of antibiotic in the
slurry is generally, 5 - 20% w/v, more suitably 8 - 15~ w/v for
example, about 10 or 12% w/v.
For step (b), the base used is most suitably a sodium or
potassium lower alkoxide such as methoxide, ethoxide, isopropoxide
or the like. Normally, the alkoxide used will be a derivative of
an alkanol used in the solvent in step (a). The base to be added
to the slurry is normally suspended or dissolved in an inert organic
solvent system such as a chlorinated hydrocarbon optionally together
with an alkanol. Preferred bases include sodium methoxide and pot-
assium methoxide.
The temperature at which step (b) is prepared will be below
25C, should be below 15C, will suitably be below 0C and will pre-
ferably be below -10C, for example, at about -20C to -25C.
The molar ratio of antibiotic present to base should not O
be less than 0.9 to 1 and should not be greater than 1 to 1.1. Most
suitably, the base is not present in excess.
For step (c), the solvent added to the solution (or vise
versa), should be such that the ability of the system to form hydro-
gen bonds is reduced by the addition of the solvent. In general,
this can occur when the solvent added is of lower dielectric constant
than the existing solution. Suitable solvents include inert organic
solvents such as hydrocarbons, chlorinated hydrocarbons, ketones
(other than acetone), lower alkanols and the like or mixtures of such
. ' ', ~ ., . "
. . , "
,; : .
' ', '

10591~8
solvents.
It will be understood that neat alkanols do not form
suitable solvents for this step unless the alkanol used in steps
(a) and (b) is methanol or ethanol and a propanol or higher alkanol
is used in step (c); even in such a case it is preferred that any
alkanol added will be in admixture with at least one non-hydrogen
bonding solvent.
The temperature at which step (c) is operated will normally
be a depressed temperature, for example, below 15C, suitably below
5C and preferably below 0C, for example at about -5C.
The isolation of the precipitate in step (d) may be any
convenient method but in general, filtration is preferred because
of ease of application. The product may be dried by known methods
conventionally used in the isolation of the relevant semi-synthetic
antibiotics, for example, by the passage of a stream of dry air.
In general, it is preferable that steps (a), (b) and (c)
do not take place in the presence of considerable quantities of water.
It is believed that the best results occur when dry reagents are
used, for example, if the solvents contain less than 0.2% of water.
Such conditions may be achieved by using dry materials and/or by
including desiccants in the reaction system. Suitable desiccants
include such conventional materials as molecular sieve, magnesium
sulphate and other inorganic salts known for this purpose. Standard
moisture excluding techniques may prove advantageous if used.
In order to obtain pure products, step (c) should be
carried out under substantially water-free conditions.
Suitable non-alkanolic solvents for use in various stages
-- 5 --
., . : ,

-- " 105~1~8
of the process include dichloromethane, chloroform, ethylene-
dichloride, C6 18 alkanes or alkenes, methylethylketone, methyl-
isobutylketone, methyl acetate, ethyl acetate, and the like.
A preferred non-alkanolic solvent for use in the
various stages of the process is dichloromethane.
A process for the preparation of the sodium or potassium
salt of amoxycillin preferably comprises (a) the formation of a
slurry of amoxycillin in a mixture of dichloromethane and methanol;
(b) bringing about the dissolution of the amoxycillin by the addi-
tion of sodium methoxide or potassium methoxide at a temperature
below 0C; (c) precipitating the resulting salt by the addition of
an organic solvent; (d) isolating the precipitated sodium or pot-
assium salt of amoxycillin.
Most suitably stage (b) is carried out at a temperature
below -10C, for example at about -20C to -25C.
Most suitably the solvent added in stage (c) is dichlor-
methane.
It is highly preferable that each of the aspects of this
invention are adapted for the preparation of the sodium salt of , ~-
amoxycillin.
The following Examples illustrate the invention.
_AMPLE 1 - SODIUM AMOXYCILLIN
Dry amoxycillin (45 g; containing approx. 4.5 - 5% water)
was slowly added with stirring to a mixture of methanol (200 ml.
water content ~0.1%) and methylene dichloride (300 ml, water content
~0.2~i). To the resulting slurry was added Molecular Sieve grade 3A
(20 - 25 ml). The slurry was cooled to -20/25C and a solution of
sodium methoxide (5.0 g) in a rnixture of methylene dichloride (100
ml, water content ~0.2%) and methanol (25 ml, water content~ 0.1~i)
,. ' ' ~ ' ,~ ~ , .. .
,
' ` ' ' ,` " '

~- - 105~118
was added dropwise to the slurry over 20 minutes during which time
the temperature was allowed to rise to -10/15C. The resulting
solution was filtered to remove insoluble materials and poured slow-
ly (over 1 - 2 minutes) into rapidly stirred mixture of methylene
dichloride (1800 ml, water content ~0.2%) and isopropanol (200 ml,
water content ~0.2%) pre-cooled to -5/10C. The resulting sus-
pension was stirred at this temperature for 30 minutes and filtered
under dry nitrogen. The resulting material was dried using a fluid-
ised bed dryer with a dry nitrogen supply at 15/20C for 30 minutes
and was thereafter stored in a vacuum oven at 15/20C for 15 hours.
The resulting sodium amoxycillin was of good purity.
EXAMPLE 2 - SODIUM AMOXYCILLIN
. .
Dry amoxycillin (45 g; containing 4 - 5~ water) was slur-
10 ried in 200 mls of methylene dichloride (water ~0.2~) and 200 mls
of methanol (water C0.1%) mixture which was then cooled to -25/30C.
Then a solution of 5.8 g of sodium methoxide in a mixture of 225 mls
methylene dichloride and 25 mls methanol was added dropwise over 30
minutes, whilst the temperature was maintained at -25/-30C. After
a further 15 - 30 minutes the undissolved solids were removed by
filtration. The resulting solution was added to 250 mls of propan-
2-ol and then 2 litres of methylene dichloride (water ~0.2%) was
added over 15 - 30 minutes whilst keeping the temperature below -5C.
The suspension was stirred for 30 minutes before being isolated by
centrifuging under a dry atmosphere. The wet cake was milled then
dried at 85C for 1 hour in a fluid-bed drier.
EXAMPLE 3 - SODIUM AMOXYCILLIN
Amoxycillin trihydrate (50 g; containing 12 - 14~ water)
was reslurried, twice in 500 mls of methanol. The solids were iso-
:, , . ," .. . .. .. :,
,. . .
,

- 1~59118
lated by filtration and the wet cake weighed. The wet cake was add-
ed to 200 mls of methylene dichloride (water /0.2~ and methanol
[260 _ weight of wet cake mls] and the slurry cooled to -25/-30C.
A solution of sodium methoxide (5.8 g) in a mixture of 225 mls of
methylene dichloride and 25 mls of methanol was added slowly over
30 minutes whilst maintaining the temperature at -25/-30C. After
a further 15 - 30 minutes, the undissolved solids were removed by
filtration and the solution added to 250 mls of propan-2-ol. This
mixture was diluted with 2 litres of methylene dichloride over 15 -
30 minutes, keeping the temperature below -5C. The slurry was
stirred for a further 15 - 30 minutes, then the solids were iso-
lated by centrifuging under a dry atmosphere. The wet cake was
milled then dried at 85C for 1 hour in a fluid-bed drier.
EXAMPLE 4 - SODIUM AMOXYCILLIN
The same process as used in Example 3 was followed,
except 5 - 10 minutes prior to recovering the solids by centrifuging
finely ground anhydrous sodium carbonate (2.3 g) was added to the
slurry.
, . . ~
. . . ",
'' ' : ' ,' ~ '~' . :
. .
, ', ' ,' ' " '' '' ' ' .
, . . .

Representative Drawing

Sorry, the representative drawing for patent document number 1059118 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC from MCD 2006-03-11
Inactive: Expired (old Act Patent) latest possible expiry date 1996-07-24
Grant by Issuance 1979-07-24

Abandonment History

There is no abandonment history.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
BEECHAM GROUP LIMITED
Past Owners on Record
ANTONY R. BERRY
IAN D. CAMBURN
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Cover Page 1994-04-23 1 14
Claims 1994-04-23 2 41
Abstract 1994-04-23 1 18
Drawings 1994-04-23 1 5
Descriptions 1994-04-23 7 249